This difference in CCL5 and CXCL4 release was also observed in platelets isolated from two patients with Glanzmann thrombasthenia, who have defective αIIbβ3integrins (Supplementary Figure S1). This evidence concerns the gene CCL5 and Glanzmann thrombasthenia.